751
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Treatment of cutaneous lichen planus (part 2): a review of systemic therapies

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 633-647 | Received 26 Jul 2018, Accepted 27 Oct 2018, Published online: 11 Dec 2018

References

  • Gorouhi F, Davari P, Fazel N. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. Sci World J. 2014;2014:742826.
  • Payette MJ, Weston G, Humphrey S, et al. Lichen planus and other lichenoid dermatoses: kids are not just little people. Clin Dermatol. 2015;33:631–643.
  • Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med. 2012;366:723–732.
  • Usatine RP, Tinitigan M. Diagnosis and treatment of lichen planus. Am Fam Physician. 2011;84:1–9.
  • Weston G, Payette M. Update on lichen planus and its clinical variants. Int J Women Dermatol. 2015;1:140–149.
  • Cribier B, Frances C, Chosidow O. Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol. 1998;134:1521–1530.
  • Antiga E, Caproni M, Parodi A, et al. Treatment of cutaneous lichen planus: an evidence based analysis of efficacy by the Italian Group for Cutaneous Immunopathology. J Ital Dematol Venereol. 2014;149:719–726.
  • Fazel N. Cutaneous lichen planus: a systematic review of treatments. J Dermatolog Treat. 2015;26:280–283.
  • Atzmony L, Reiter O, Hodak E, et al. Treatments for cutaneous lichen planus: a systematic review and meta-analysis. Am J Clin Dermatol. 2016;17:11–22.
  • Lehman JS, Tollefson MM, Gibson LE. Lichen planus. Int J Dermatol. 2009;48:682–694.
  • Asch S, Goldenberg G. Systemic treatment of cutaneous lichen planus: an update. Cutis. 2011;87:129–134.
  • Puza C, Cardones A. Concepts and controversies in the treatment of cutaneous lichen planus. G Ital Dermatol Venereol. 2017;152:607–614.
  • Manousaridis I, Manousaridis K, Peitsch WK, et al. Individualizing treatment and choice of medication in lichen planus: a step by step approach. J Dtsch Dermatol Ges. 2013;11:981–991.
  • Samycia M, Lin AN. Efficacy of topical calcineurin inhibitors in lichen planus. J Cutan Med Surg. 2012;16:221–229.
  • Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–926.
  • Schünemann H, Hill S, Guyatt G, et al. The GRADE approach and Bradford Hill's criteria for causation. J Epidemiol Community Health. 2011;65:392–395.
  • Iraji F, Asilian A, Saeidi A, et al. Comparison of therapeutic effect of low-dose low-molecular-weight heparin (enoxaparin) vs. oral prednisone in treatment of patients with lichen planus; a clinical trial. Adv Biomed Res. 2013;2:1–5.
  • Sachan S, Chaudhary SS, Prateek K, et al. A prospective study comparing therapeutic efficacy and safety of oral methotrexate and oral prednisone in the treatment of generalized cutaneous lichen planus. J Dent Med Sci. 2017;16:143–147.
  • Iraji F, Faghihi G, Asilian A, et al. Comparison of the narrow band UVB versus systemic corticosteroids in the treatment of lichen planus: a randomized clinical trial. J Res Med Sci. 2011;16:1578–1582.
  • Kellett J, Ead R. Treatment of lichen planus with a short course of oral prednisolone. Br J Dermatol. 1990;123:550–551.
  • Ramesh M, Balachandran C, Shenoi S, et al. Efficacy of steroid oral mini-pulse therapy in lichen planus: an open trial in 35 patients. Indian J Dermatol Venereol Leprol. 2006;72:156.
  • Hazra S, Choudhury A, Khondker L, et al. Comparative efficacy of methotrexate and mini pulse betamethasone in the treatment of lichen planus. Mymensingh Med J. 2013;22:787–797.
  • Snyder RA, Schwartz RA, Schneider JS, et al. Intermittent megadose corticosteroid therapy for generalized lichen planus. J Am Acad Dermatol. 1982;6:1089–1090.
  • Hazra S, Choudhury A, Asaduzzaman A, et al. Adverse outcome of methotrexate and mini pulse betamethasone in the treatment of lichen planus. Bangladesh Med Res Counc Bull. 2013;39:22–27.
  • Verma KK, Mittal R, Manchanda Y. Lichen planus treated with betamethasone oral mini-pulse therapy. Indian J Dermatol Venereol Leprol. 2000;66:34.
  • Vazirnia A, Cohen PR. Acitretin for the management of generalized cutaneous lichen planus. Dermatol Online J. 2014;20:1–7.
  • Plewig G. Retinoids in lichen planus. Dermatology (Basel). 1997;194:311–312.
  • Brehmer F, Haenssle HA, Schön MP, et al. Response of recalcitrant lichen planus to alitretinoin in 3 patients. J Am Acad Dermatol. 2011;65:e58–e60.
  • Laurberg G, Geiger J-M, Hjorth N, et al. Treatment of lichen planus with acitretin: a double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol. 1991;24:434–437.
  • Muthu SK, Narang T, Saikia UN, et al. Low‐dose oral isotretinoin therapy in lichen planus pigmentosus: an open‐label non‐randomized prospective pilot study. Int J Dermatol. 2016;55:1048–1054.
  • Viglioglia PA, Villanueva CR, Martorano AD, et al. Efficacy of acitretin in severe cutaneous lichen planus. J Am Acad Dermatol. 1990;22:852–853. PubMed PMID: 2140841; eng.
  • Schuppli R. The efficacy of a new retinoid (Ro 10-9359) in lichen planus. Dermatol. 1978;157:60–63.
  • Ott F, Bollag W, Geiger J-M. Efficacy of oral low-dose tretinoin (all-trans-retinoic acid) in lichen planus. Dermatology (Basel). 1996;192:334–336.
  • Bollag W, Ott F. Treatment of lichen planus with temarotene. Lancet. 1989;2:974.
  • Kolios AG, Marques Maggio E, Gubler C, et al. Oral, esophageal and cutaneous lichen ruber planus controlled with alitretinoin: case report and review of the literature. Dermatol. 2013;226:302–310.
  • Molin S, Ruzicka T. Oral alitretinoin in lichen planus: two case reports. Acta Derm Venereol. 2010;90:523–524.
  • Woo TY. Systemic isotretinoin treatment of oral and cutaneous lichen planus. Cutis. 1985;35:385–386, 390–391, 393.
  • Viglioglia PA. Therapeutic evaluation of the oral retinoid Ro 10-9359 in several non-psoriatic dermatoses. Br J Dermatol. 1980;103:483–488.
  • Kanzaki T, Otake N, Nagai M. Eruptive lichen planus. J Dermatol. 1992;19:234–237.
  • Aram H. Association of Lichen Planus and Lichen Nitidus. Treatment with etretinate. Int J Dermatol. 1988;27:117.
  • Bhuiyan I, Wahab M, Ali A, et al. Comparative efficacy of hydroxychloroquine and griseofulvin in the treatment of lichen planus. J Pakistan Ass Dermatol. 2010;20:79–83.
  • Libow L, Coots N. Treatment of lichen planus and lichen nitidus with itraconazole: reports of six cases. Cutis. 1998;62:247–248.
  • Sehgal V, Bikhchandani R, Koranne R, et al. Histopathological evaluation of griseofulvin therapy in lichen planus. A double-blind controlled study. Dermatol. 1980;161:22–27.
  • Sehgal V, Abraham G, Malik G. Griseofulvin therapy in lichen planus. A double-blind controlled trial. Br J Dermatol. 1972;87:383–385.
  • Levy A, Stempler D, Yuzuk S, et al. Treatment of lichen planus with griseofulvin. Int J Dermatol. 1986;25:405.
  • Massa MC, Rogers RS, 3rd. Griseofulvin therapy of lichen planus. Acta Derm Venereol. 1981;61:547–550. PubMed PMID: 6177168; eng.
  • Ali M, Kawsar N. Low molecular weight heparin-an alternative therapy for lichen planus. J Arm Forces Med Col, Bangladesh. 2014;9:1.
  • Hodak E, Yosipovitch G, David M. Low-dose low-molecular-weight hepain (enoxaparin) is beneficial in lichen planus: a preliminary report. Indian J Dermatol Venerology Leprol. 1998;38:564–568.
  • Akdeniz S, Harman M, Atmaca S, et al. The management of lichen planus with low-molecular-weight heparin (enoxaparin). Int J Clin Pract. 2005;59:1268–1271.
  • Ferahbas A, Uksal U, Kutlugun C, et al. Low‐molecular‐weight heparin (enoxaparin) in the treatment of lichen planus. J Eur Acad Dermatol Venerol. 2003;17:604–605.
  • Rai R, Kaur I, Kumar B. Low-dose low-molecular-weight heparin in lichen planus. J Am Acad Dermatol. 2002;46:141–143.
  • Stefanidou M, Ioannidou D, Panayiotides J, et al. Low molecular weight heparin; a novel alternative therapeutic approach for lichen planus. Br J Dermatol. 1999;141:1040–1045.
  • Lunge S, Patil S, Manjunathswamy B. A comparative study of methotrexate & low molecular weight heparin for the treatment of generalized lichen planus. Ind J Dermatol Venereol Leprol. 2016;2:153–158.
  • Khan M, Uddin M, Shah M, et al. Efficacy of low dose low molecular weight heparin in the treatment of cutaneous lichen planus. J Arm Forces Med Col, Bangladesh. 2013;9:2–7.
  • Uçmak D, Balcı G, Harman M. The effectiveness of treatment with enoxaparin in lichen planus. J Clin Exp Invest. 2012;3:172–173.
  • Ameen WA, Alfadhily ZS. Treatment of recalcitrant lichen planus with low molecular weight heparin (Enoxaparin): a case series study among Iraqi patients. Med J Babylon. 2011;8:93–103.
  • Forsea A, Telipan M, Braileanu A, et al. Low-molecular weight heparin therapy in lichen planus: 5 years of clinical experience. J Eur Acad Dermatol Venereol. 2005;19:91.
  • Hewitt CW, Black KS. Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants. Google Patents. 1996;922–923.
  • More YE, Khatu SS, Chavan DC, et al. Evaluation of safety and efficacy of low-dose methotrexate as an alternative treatment option to systemic corticosteroids in generalized lichen planus. Med J DY Patil Univ. 2017;10:149.
  • Kanwar A, De D. Methotrexate for treatment of lichen planus: old drug, new indication. J Eur Acad Dermatol Venereol. 2013;27:410–413.
  • Turan H, Baskan EB, Tunali S, et al. Methotrexate for the treatment of generalized lichen planus. J Am Acad Dermatol. 2009;60:164–166.
  • Verma KK, Sirka CS, Khaitan BK. Generalized severe lichen planus treated with azathioprine. Acta Dermato-Venereologica. 1999;79:493.
  • Klein LR, Callen JP. Azathioprine: effective steroid-sparing therapy for generalized lichen planus. South Med J. 1992;85:198.
  • Levell N, Munro C, Marks JM. Severe lichen planus clears with very low-dose cyclosporin. Br J Dermatol. 1992;127:66–67.
  • Higgins E, Munro C, Friedmann P, et al. Cyclosporin A in the treatment of lichen planus. Arch Dermatol. 1989;125:1436.
  • Ho VC, Gupta AK, Ellis CN, et al. Treatment of severe lichen planus with cyclosporine. J Am Acad Dermatol. 1990;22:64–68.
  • Frieling U, Bonsmann G, Schwarz T, et al. Treatment of severe lichen planus with mycophenolate mofetil. J Am Acad Dermatol. 2003;49:1063–1066.
  • Nousari HC, Goyal S, Anhalt GJ. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil. Arch Dermatol. 1999;135:1420–1421.
  • Holliday AC, Moody MN, Berlingeri-Ramos A. Methotrexate: role of treatment in skin disease. Skin Therapy Lett. 2013;18:4–9.
  • Farshi S, Mansouri P, Safar F, et al. Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study. Int J Dermatol. 2010;49:1188–1193.
  • Verma KK, Sirka CS, Khaitan BK. Generalized severe lichen planus treated with azathioprine. Oncol. 1999;11:409–416.
  • Faulds D, Goa KL, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs. 1993;45:953–1040. PubMed PMID: 7691501; eng.
  • Omidian M, Ayoobi A, Mapar M, et al. Efficacy of sulfasalazine in the treatment of generalized lichen planus: randomized double‐blinded clinical trial on 52 patients. J Eur Acad Dermatol Venereol. 2010;24:1051–1054.
  • Bauza A, España A, Gil P, et al. Successful treatment of lichen planus with sulfasalazine in 20 patients. Int J Dermatol. 2005;44:158–162.
  • Moura A, Moure E, Romiti R. Treatment of cutaneous lichen planus with thalidomide. Clin Exp Dermatol. 2009;34:101–103.
  • Doherty SD, Hsu S. A case series of 48 patients treated with thalidomide. J Drugs Dermatol. 2008;7:769–773.
  • Maender J, Krishnan R, Angel T, et al. Complete resolution of generalized lichen planus after treatment with thalidomide. J Drug Dermatol. 2005;4:86–88.
  • Pérez RA, Weiss E, Piquero JM, et al. Generalized lichen planus with erosive lesions of the penis, treated with thalidomide. Report of a case and review of the literature. Med Cut Ibero Lat Am. 1987;15:321–326.
  • Sharma L, Mishra M. A comparative study of PUVASOL therapy in lichen planus. Indian J Dermatol Venereol Leprol. 2003;69:212.
  • Chopra A, Mittal R, Kaur B. Dapsone versus corticosteroids in lichen planus. Indian J Dermatol Venereol Leprol. 1999;65:66.
  • Rasi A, Behzadi AH, Davoudi S, et al. Efficacy of oral metronidazole in treatment of cutaneous and mucosal lichen planus. J Drugs Dermatol. 2010;9:1186–1190.
  • Büyük AY, Kavala M. Oral metronidazole treatment of lichen planus. J Am Acad Dermatol. 2000;43:260–262.
  • Wahba-Yahav AV. Idiopathic lichen planus: treatment with metronidazole. J Am Acad Dermatol. 1995;33:301–305.
  • Wahba-Yahav AV. Intestinal amebiasis, lichen planus, and treatment with metronidazole. J Am Acad Dermatol. 1989;20:1128–1129.
  • Shelley WB, Shelley ED. Urinary tract infection as a cause of lichen planus: metronidazole therapy. J Am Acad Dermatol. 1984;10:905–907.
  • Kumar B, Kaur I, Sharma VK. Efficacy of dapsone in lichen planus. Indian J Dermatol Venereol Leprol. 1989;55:164–166.
  • Hantash B, Kanzler M. The efficacy of tetracycline antibiotics for treatment of lichen planus: an open-label clinical trial. BR J Dermatol. 2007;156:758–760.
  • Albers SE, Glass L, Fenske NA. Lichen planus subtropicus: direct immunofluorescence findings and therapeutic response to hydroxychloroquine. Int J Dermatol. 1994;33:645–644.
  • Schewach-Millet M, Shpiro D, Sofer E. Actinic lichen planus: treatment with antimalarials. J Am Acad Dermatol. 1990;22:325.
  • Chao TJ. Adalimumab in the management of cutaneous and oral lichen planus. Cutis. 2009;84:325–328.
  • Böhm M, Luger TA. Lichen planus responding to efalizumab. J Am Acad Dermatol. 2007;56:S92–S93.
  • Fivenson DP, Mathes B. Treatment of generalized lichen planus with alefacept. Arch Dermatol. 2006;142:151–152.
  • Hildebrand A, Kolde G, Luger TA, et al. Successful treatment of generalized lichen planus with recombinant interferon alfa-2b. J Am Acad Dermatol. 1995;33:880–883.
  • Holló P, Szakonyi J, Kiss D, et al. Successful treatment of lichen planus with adalimumab. Acta Derm Venereol. 2012;92:385–386.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.